SCHEMBL21928083

SCHEMBL21928083

N#Cc1cccnc1-c1cccc(-c2ccccc2-n2c3ccccc3c3ccccc32)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 2/20 0.38
CNR2 P34972 1/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
MAPK1 P28482 1/20 0.37
KMT2A Q03164 1/20 0.37
GABRA1 P14867 5/20 0.36
GABRG2 P18507 5/20 0.36
GABRB3 P28472 5/20 0.36
GABRA2 P47869 4/20 0.36
GABRA5 P31644 3/20 0.36
GABRA3 P34903 3/20 0.36
ALDH1A1 P00352 1/20 0.36
HTT P42858 1/20 0.36
HSD17B10 Q99714 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HIF1A Q16665 1/20 0.36
CYP19A1 P11511 1/20 0.36
PDE4B Q07343 1/20 0.35
CYP11B2 P19099 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21928142 0.93 TDO2 (0.37) METAP2CNR2GABRA1GABRG2GABRB3
SCHEMBL21927473 0.93 METAP2 (0.36) METAP2CNR2KDM4EMAPTMAPK1
SCHEMBL21927899 0.89 CNR2 (0.42) METAP2CNR2KDM4EMAPTMAPK1
SCHEMBL21397052 0.88 KDM4E (0.35) METAP2KDM4EMAPTMAPK1KMT2A
SCHEMBL21927387 0.88 METAP2 (0.32) METAP2CNR2KDM4EMAPTMAPK1
SCHEMBL21928315 0.88 METAP2 (0.32) METAP2CNR2KDM4EMAPTMAPK1
SCHEMBL21929600 0.86 PDE4B (0.39) METAP2CNR2KDM4EMAPTMAPK1
SCHEMBL21928162 0.86 METAP2 (0.39) METAP2CNR2KDM4EMAPTMAPK1
SCHEMBL21922215 0.85 METAP2 (0.40) METAP2CNR2KDM4EMAPTMAPK1
SCHEMBL28372292 0.85 GABRG2 (0.42) MAPK1GABRA1GABRG2GABRB3GABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200131150-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200131150-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CCNT1, CCNA1, CCNE2 METAP2 4618/4885CNR2 1114/4885KDM4E 3872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.